» Articles » PMID: 32473077

Highly Expressed Tumoral Emmprin and Stromal CD73 Predict a Poor Prognosis for External Auditory Canal Carcinoma

Overview
Journal Cancer Sci
Specialty Oncology
Date 2020 May 31
PMID 32473077
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Squamous cell carcinoma of the external auditory canal (SCC-EAC) is rare and has a poor prognosis. The SCC-EAC cases with high-grade tumor budding (TB) or poorly differentiated clusters (PDCs) are associated with shorter survival than those with low-grade TB or PDCs. Extracellular matrix metalloproteinase inducer (emmprin) is a protein expressed in tumor cells that stimulates the production of MMP-2 by stromal fibroblasts to facilitate tumor invasion. Recently, we reported that emmprin forms a complex with CD73 to regulate MMP-2 production from fibroblasts in vitro. Here, we examined the association of emmprin and CD73 expression with TB or PDCs as well as with survival in 34 biopsy specimens of SCC-EAC patients. High tumoral emmprin expression was associated with high-grade TB, whereas high stromal CD73 expression was associated with high-grade PDCs. Furthermore, concurrent elevated expression of tumoral emmprin and stromal CD73 was determined to be an independent poor prognostic factor. In immunoprecipitation analyses, complex formation between emmprin and CD73 was demonstrated in vitro. Production of MMP-2 from fibroblasts was more abundant when cocultured with tumor cells than from fibroblasts cultured alone. Furthermore, MMP-2 production was reduced by the transfection of CD73 siRNA in fibroblasts cocultured with tumor cells. The colocalization of emmprin and CD73 was enhanced in not only the peripheral cells of the tumor cell clusters that interact with fibroblasts but also in the cells of intratumor clusters. Overall, this study provides novel insights into the roles of emmprin, CD73, and MMP-2 in tumor invasiveness.

Citing Articles

Biological and genetic characterization of a newly established human external auditory canal carcinoma cell line, SCEACono2.

Komune N, Sato K, Ono M, Imaizumi A, Masuda S, Itoyama S Sci Rep. 2023; 13(1):19636.

PMID: 37949965 PMC: 10638439. DOI: 10.1038/s41598-023-46926-y.


Impact of Positive-Margin Resection of External Auditory Canal Squamous Cell Carcinoma.

Komune N, Kuga R, Hongo T, Kuga D, Sato K, Nakagawa T Cancers (Basel). 2023; 15(17).

PMID: 37686564 PMC: 10486369. DOI: 10.3390/cancers15174289.


Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.

Eskandari-Malayeri F, Rezaei M Front Immunol. 2022; 13:996145.

PMID: 36275750 PMC: 9581325. DOI: 10.3389/fimmu.2022.996145.


[Current status of the diagnosis and treatment of temporal bone squamous cell carcinoma].

Xiao L, Liu A, Ma H, Jiang H Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022; 36(7):559-565.

PMID: 35822388 PMC: 10128389. DOI: 10.13201/j.issn.2096-7993.2022.07.017.


Pan-Cancer Analysis, Reveals COVID-19-Related BSG as a Novel Marker for Treatment and Identification of Multiple Human Cancers.

Huang T, He W Front Cell Dev Biol. 2022; 10:876180.

PMID: 35646943 PMC: 9136262. DOI: 10.3389/fcell.2022.876180.


References
1.
Wu X, He X, Chen Y, Yuan R, Zeng Y, Lian L . High expression of CD73 as a poor prognostic biomarker in human colorectal cancer. J Surg Oncol. 2012; 106(2):130-7. DOI: 10.1002/jso.23056. View

2.
Nabeshima K, Iwasaki H, Koga K, Hojo H, Suzumiya J, Kikuchi M . Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int. 2006; 56(7):359-67. DOI: 10.1111/j.1440-1827.2006.01972.x. View

3.
Ma X, Shen M, Hu B, Wang B, Yang W, Lv L . CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis. J Hematol Oncol. 2019; 12(1):37. PMC: 6458749. DOI: 10.1186/s13045-019-0724-7. View

4.
Overall C, Sodek J . Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. J Biol Chem. 1990; 265(34):21141-51. View

5.
Sweeny L, Dean N, Frederick J, Magnuson J, Carroll W, Desmond R . CD147 expression in advanced cutaneous squamous cell carcinoma. J Cutan Pathol. 2012; 39(6):603-9. PMC: 3634338. DOI: 10.1111/j.1600-0560.2012.01912.x. View